trending Market Intelligence /marketintelligence/en/news-insights/trending/S_sLNryjNHCqUobk1hlfbg2 content esgSubNav
In This List

Medtronic's neurosurgery guidance system receives US FDA clearance

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Medtronic's neurosurgery guidance system receives US FDA clearance

The U.S. Food and Drug Administration has cleared Medtronic PLC's Stealth Autoguide system, a robotic surgery platform that provides positioning assistance during neurosurgical procedures.

Medtronic's robotic platform helps surgeons prepare and carry out precise procedures as part of the company's Surgical Synergy platform.

Dublin-based Medtronic develops device-based medical therapies.